MiMedx Group, Inc. and Subsidiaries
Non-GAAP Financial Measures and ReconciliationAs used herein, "GAAP", refers to generally accepted accounting principles in the United States. We use various numerical measures in conference calls, investor meetings and other forums which are or may be considered "Non-GAAP financial measures" under Regulation G. We have provided below for your reference, supplemental financial disclosure for these measures, including the most directly comparable GAAP measure and an associated reconciliation.
Reconciliation of Net Loss to "Adjusted EBITDA" defined as Earnings before Interest, Taxes, Depreciation, Amortization and Share Based Compensation:Three Months Ended June 30,Six Months Ended June 30,2013201220132012Net Loss (Per GAAP)
(1,837,721)Add back:Income Taxes--50,275-Financing expense associated with beneficial
conversion of note payable issued in
with acquisition-86,335-166,688Financing expense associated with beneficial
conversion of Line of Credit with Related Party-150,880-162,303Financing expense associated with beneficial
conversion of Senior Secured Promissory Notes-235,5341,328,439454,235Other interest expense, net13,172153,80427,976305,614Depreciation Expense139,184121,103237,934231,491Amortization Expense267,638333,977530,234667,954Share Based Compensation1,502,447585,2152,487,2391,086,200Earnings Before Interest, Taxes, Depreciation, Amortization and Share-Based Compensation
|SOURCE MiMedx Group, Inc.|
Copyright©2012 PR Newswire.
All rights reserved